FY2025 · period end Dec '25 · from the 10-K filed Mar 16, 2026
Data as filed with the SEC, provided for information only — not investment advice.
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Revenue | $6.32B | $5.97B | $5.41B | $5.13B |
| Gross Profit | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | $0.14B | $0.21B | $0.05B | $0.19B |
| EPS (Diluted) | $0.96 | $1.58 | $0.43 | $1.50 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Total Assets | $5.29B | $4.96B | $4.73B | — |
| Total Liabilities | $3.61B | $3.43B | $3.65B | — |
| Stockholders' Equity | $1.69B | $1.52B | $1.08B | $1.04B |
| Cash & Equivalents | $0.71B | $0.56B | $0.44B | — |
| Total Debt | $1.08B | $1.09B | $1.17B | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Operating Cash Flow | $0.47B | $0.32B | $0.22B | negative: -$0.04B |
| Capital Expenditures | — | — | — | — |
| Free Cash Flow | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Gross Margin | — | — | — | — |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Return on Equity | 8.5% | 16.2% | 5.1% | 18.2% |
| Return on Assets | 2.7% | 4.3% | 1.1% | — |
| Debt / Equity | 0.64× | 0.71× | 1.09× | — |
Showing the most recent 4 annual periods. Get 15 years of history on the Pro plan, or full history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001628280-26-060735 | Sep 4, 2026 | Sep 4, 2026 | Sep 4, 2026 20:16 UTC | EDGAR |
| 10-Q | 0001628280-26-055215 | Jun 30, 2026 | Aug 10, 2026 | Aug 10, 2026 20:07 UTC | EDGAR |
| 8-K | 0001628280-26-052598 | Aug 4, 2026 | Aug 4, 2026 | Aug 4, 2026 20:16 UTC | EDGAR |
| 8-K | 0001628280-26-046247 | Jun 26, 2026 | Jun 30, 2026 | Jun 30, 2026 20:33 UTC | EDGAR |
| 8-K | 0001193125-26-253567 | Jun 2, 2026 | Jun 2, 2026 | Jun 2, 2026 20:23 UTC | EDGAR |
| 8-K | 0001628280-26-038152 | May 20, 2026 | May 26, 2026 | May 26, 2026 20:37 UTC | EDGAR |
| 10-Q | 0001628280-26-031299 | Mar 31, 2026 | May 6, 2026 | May 6, 2026 20:19 UTC | EDGAR |
| 8-K | 0001628280-26-030552 | May 5, 2026 | May 5, 2026 | May 5, 2026 20:15 UTC | EDGAR |
Direct links to SEC EDGAR. ARDT has additional filings available on the SEC site.
Who is buying and selling Ardent Health, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on ARDT yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on ARDT and publish the result to your public profile.
Ask about Ardent Health, Inc.
Continue in Workspace — cited answers on ARDT, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs